All Stories

  1. Botanical drugs: a new strategy for structure-based target prediction

    Article • Briefings in Bioinformatics, October 2021, Oxford University Press (OUP)

    Professor shang hongcai

  2. Integrating Chinese and western medicine for COVID‐19: A living evidence‐based guideline (version 1)

    Article • Journal of Evidence-Based Medicine, October 2021, Wiley

    Professor shang hongcai

  3. Methods for development of a core outcome set for clinical trials integrating traditional Chinese medicine and Western medicine

    Article • Journal of Integrative Medicine, September 2021, Elsevier

    Professor shang hongcai

  4. Evaluating the methodology of studies conducted during the global COVID-19 pandemic: A systematic review of randomized controlled trials

    Article • Journal of Integrative Medicine, July 2021, Elsevier

    Professor shang hongcai

  5. Development of a Core Outcome Set for the Benefits and Adverse Events of Acute Heart Failure in Clinical Trials of Traditional Chinese Medicine and Western Medicine: A Study Protocol

    Article • Frontiers in Medicine, May 2021, Frontiers

    Professor shang hongcai

  6. Phenotypical Changes of Hematopoietic Stem and Progenitor Cells in Sepsis Patients: Correlation With Immune Status?

    Article • Frontiers in Pharmacology, January 2021, Frontiers

    Professor shang hongcai

  7. Novel Risk Stratification for Chemotherapy-Induced Heart Failure

    Article • JACC Heart Failure, April 2019, Elsevier

    Professor shang hongcai

  8. Clinical practice guidelines in China

    Article • BMJ, February 2018, BMJ

    Professor shang hongcai

  9. Comparative Effectiveness of Acupuncture and Antiarrhythmic Drugs for the Prevention of Cardiac Arrhythmias: A Systematic Review and Meta-analysis of Randomized Controlled Trials

    Article • Frontiers in Physiology, June 2017, Frontiers

    Professor shang hongcai

  10. The Role of Biologically Active Ingredients from Chinese Herbal Medicines in the Regulation of Autophagy in Treating Cardiovascular Diseases and Other Chronic Diseases

    Article • Current Pharmaceutical Design, April 2017, Bentham Science Publishers

    Professor shang hongcai

  11. Niuhuang Jiangya Preparation (a traditional Chinese patent medicine) for essential hypertension: A systematic review

    Article • Complementary Therapies in Medicine, April 2017, Elsevier

    Professor shang hongcai

  12. Effects of exercise-based cardiac rehabilitation in patients after percutaneous coronary intervention: A meta-analysis of randomized controlled trials

    Article • Scientific Reports, March 2017, Nature

    Professor shang hongcai

  13. The dark side of “the force” – lipid nanoparticles enhance the oncogenesis of diethylnitrosamine and result in liver cancer in mice

    Article • Nanomedicine Nanotechnology Biology and Medicine, February 2017, Elsevier

    Professor shang hongcai

  14. Effects of Wenxin Keli on Cardiac Hypertrophy and Arrhythmia via Regulation of the Calcium/Calmodulin Dependent Kinase II Signaling Pathway

    Article • BioMed Research International, January 2017, Hindawi Publishing Corporation

    Professor shang hongcai

  15. 10.1111/wvn.12127

    Article • Scientific Reports, April 2016, Nature

    Professor shang hongcai

  16. Xuebijing injection in the treatment of severe pneumonia: study protocol for a randomized controlled trial

    Article • Current Controlled Trials in Cardiovascular Medicine, March 2016, Springer Science + Business Media

    Professor shang hongcai

  17. Reporting of core items in hierarchical Bayesian analysis for aggregating N-of-1 trials to estimate population treatment effects is suboptimal

    Article • Journal of Clinical Epidemiology, March 2016, Elsevier

    Professor shang hongcai

  18. Nursing Practice Guidelines in China do Need Reform: A Critical Appraisal Using the AGREE II Instrument

    Article • Worldviews on Evidence-Based Nursing, January 2016, Wiley

    Professor shang hongcai

  19. Urgent need to improve the quality of case report in traditional Chinese medicine: Assessment on reporting quality of 3,417 cases

    Article • Chinese Journal of Integrative Medicine, January 2016, Springer Science + Business Media

    Professor shang hongcai

  20. Mouse hepatic neoplasm formation induced by trace level and low frequency exposure to diethylnitrosamine through β-catenin signaling pathway

    Article • Toxicology Research, January 2016, Oxford University Press (OUP)

    Professor shang hongcai

  21. Formulation, optimization, and pharmacodynamic evaluation of chitosan/phospholipid/β-cyclodextrin microspheres

    Article • Drug Design Development and Therapy, January 2016, Dove Medical Press

    Professor shang hongcai

  22. Drug-symptom networking: Linking drug-likeness screening to drug discovery

    Article • Pharmacological Research, January 2016, Elsevier

    Professor shang hongcai

  23. 10.1038/srep19809

    Article • Chinese Journal of Integrative Medicine, December 2015, Springer Science + Business Media

    Professor shang hongcai

  24. Tetramethylpyrazine Promotes Migration of Neural Precursor Cells via Activating the Phosphatidylinositol 3-Kinase Pathway

    Article • Molecular Neurobiology, November 2015, Springer Science + Business Media

    Professor shang hongcai

  25. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design

    Article • Current Controlled Trials in Cardiovascular Medicine, November 2015, Springer Science + Business Media

    Professor shang hongcai

  26. Gynura procumbens Reverses Acute and Chronic Ethanol-Induced Liver Steatosis through MAPK/SREBP-1c-Dependent and -Independent Pathways

    Article • Journal of Agricultural and Food Chemistry, September 2015, American Chemical Society (ACS)

    Professor shang hongcai

  27. Clinical assessment of Shenfu injection loading in the treatment of patients with exacerbation of chronic heart failure due to coronary heart disease: study protocol for a randomized controlled trial

    Article • Current Controlled Trials in Cardiovascular Medicine, May 2015, Springer Science + Business Media

    Professor shang hongcai

  28. Liver Damage Associated withPolygonum multiflorumThunb.: A Systematic Review of Case Reports and Case Series

    Article • Evidence-based Complementary and Alternative Medicine, January 2015, Hindawi Publishing Corporation

    Professor shang hongcai

  29. Clinical trials of acupuncture and moxibustion

    Article • European Journal of Integrative Medicine, December 2014, Elsevier

    Professor shang hongcai

  30. CUPID: a protocol of a randomised controlled trial to identify characteristics of similar Chinese patent medicines

    Article • BMJ Open, November 2014, BMJ

    Professor shang hongcai

  31. The Pharmacological Actions of Danshen ThemeD Formulas

    Article • October 2014, Springer Science + Business Media

    Professor shang hongcai

  32. Endorsement of CONSORT by Chinese medical journals: A survey of “instruction to authors”

    Article • Chinese Journal of Integrative Medicine, June 2014, Springer Science + Business Media

    Professor shang hongcai

  33. Status and thoughts of Chinese patent medicines seeking approval in the US market

    Article • Chinese Journal of Integrative Medicine, June 2014, Springer Science + Business Media

    Professor shang hongcai

  34. Use of comparative effectiveness research for similar Chinese patent medicine for angina pectoris of coronary heart disease: a new approach based on patient-important outcomes

    Article • Current Controlled Trials in Cardiovascular Medicine, January 2014, Springer Science + Business Media

    Professor shang hongcai

  35. The Antihyperglycemic Effects of Rhizoma Coptidis and Mechanism of Actions: A Review of Systematic Reviews and Pharmacological Research

    Article • BioMed Research International, January 2014, Hindawi Publishing Corporation

    Professor shang hongcai

  36. Buyang Huanwu Decoction for Healthcare: Evidence-Based Theoretical Interpretations of Treating Different Diseases with the Same Method and Target of Vascularity

    Article • Evidence-based Complementary and Alternative Medicine, January 2014, Hindawi Publishing Corporation

    Professor shang hongcai

  37. GAP: From Sound Design to Practical Implementation in Clinical Trials for Traditional Chinese Medicine

    Article • Evidence-based Complementary and Alternative Medicine, January 2014, Hindawi Publishing Corporation

    Professor shang hongcai, Prof Nicola Robinson

  38. Traditional Chinese medicine for myocardial infarction: an overview

    Article • International Journal of Clinical Practice, November 2013, Wiley

    Professor shang hongcai

  39. GW24-e1798 Clinical evidence of Chinese medicine prevention and treatment to chronic heart failure

    Article • Heart, August 2013, BMJ

    Professor shang hongcai

  40. Qi-Shen-Yi-Qi Dripping Pills for the Secondary Prevention of Myocardial Infarction: A Randomised Clinical Trial

    Article • Evidence-based Complementary and Alternative Medicine, January 2013, Hindawi Publishing Corporation

    Professor shang hongcai

  41. The Effects of Wenxin Keli on P-Wave Dispersion and Maintenance of Sinus Rhythm in Patients with Paroxysmal Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials

    Article • Evidence-based Complementary and Alternative Medicine, January 2013, Hindawi Publishing Corporation

    Professor shang hongcai

  42. Is Deqi an Indicator of Clinical Efficacy of Acupuncture? A Systematic Review

    Article • Evidence-based Complementary and Alternative Medicine, January 2013, Hindawi Publishing Corporation

    Professor shang hongcai

  43. The key role of Shenyan Kangfu tablets, a Chinese patent medicine for diabetic nephropathy: study protocol for a randomized, double-blind and placebo-controlled clinical trial

    Article • Current Controlled Trials in Cardiovascular Medicine, January 2013, Springer Science + Business Media

    Professor shang hongcai

  44. Wenxin-Keli Regulates the Calcium/Calmodulin-Dependent Protein Kinase II Signal Transduction Pathway and Inhibits Cardiac Arrhythmia in Rats with Myocardial Infarction

    Article • Evidence-based Complementary and Alternative Medicine, January 2013, Hindawi Publishing Corporation

    Professor shang hongcai

  45. Potential effectiveness of traditional Chinese medicine for cardiac syndrome X (CSX): a systematic review and meta-analysis

    Article • BMC Complementary and Alternative Medicine, January 2013, Springer Science + Business Media

    Professor shang hongcai

  46. Target dIsease-Guided placEbo-contRolled (TIGER) design: a novel method for clinical trials of acupuncture

    Article • Current Controlled Trials in Cardiovascular Medicine, January 2013, Springer Science + Business Media

    Professor shang hongcai

  47. Understanding Patient Values and the Manifestations in Clinical Research with Traditional Chinese Medicine—With Practical Suggestions for Trial Design and Implementation

    Article • Evidence-based Complementary and Alternative Medicine, January 2013, Hindawi Publishing Corporation

    Professor shang hongcai

  48. Clinical Research of Traditional Chinese Medicine Needs to Develop Its Own System of Core Outcome Sets

    Article • Evidence-based Complementary and Alternative Medicine, January 2013, Hindawi Publishing Corporation

    Professor shang hongcai

  49. Clinical evidence of traditional Chinese medicine for the prevention and treatment of chronic heart failure

    Article • World Journal of Cardiovascular Diseases, January 2013, Scientific Research Publishing, Inc,

    Professor shang hongcai

  50. The Method of Research Subject Chosen and Clinical Orientation in the Secondary Development of Famous and Excellent Chinese Patent Medicines

    Article • Alternative & Integrative Medicine, January 2013, OMICS Publishing Group

    Professor shang hongcai

  51. Electro-Acupuncture-Related Adverse Events: A Systematic Review

    Article • Medical Acupuncture, June 2012, Mary Ann Liebert Inc

    Professor shang hongcai

  52. Quality of herbal medicines: Challenges and solutions

    Article • Complementary Therapies in Medicine, February 2012, Elsevier

    Professor shang hongcai

  53. Compound Salvia Miltiorrhiza Preparation for the Treatment of Retinal Vein Occlusion: A Systematic Review

    Article • Journal of Diabetes & Metabolism, January 2012, OMICS Publishing Group

    Professor shang hongcai

  54. Cochrane Systematic Reviews of Chinese Herbal Medicines: An Overview

    Article • PLoS ONE, December 2011, PLOS

    Professor shang hongcai

  55. Tai Chi for hypertension

    Article • Cochrane Database of Systematic Reviews, October 2011, Wiley

    Professor shang hongcai

  56. Assessing the Quality of Reports about Randomized Controlled Trials of Acupuncture Treatment on Mild Cognitive Impairment

    Article • PLoS ONE, February 2011, PLOS

    Professor shang hongcai

  57. Acupuncture-related adverse events: a systematic review of the Chinese literature

    Article • Bulletin of the World Health Organization, December 2010, WHO Press

    Professor shang hongcai

  58. Adverse drug reactions of Shenmai injection: a systematic review

    Article • Journal of Evidence-Based Medicine, August 2010, Wiley

    Professor shang hongcai

  59. How to connect the gap between clinical trials and clinical practice

    Article • Chinese Journal of Integrative Medicine, December 2008, Springer Science + Business Media

    Professor shang hongcai

  60. Evidence-Based Medicine in Traditional Chinese Medicine: Collision and Combination

    Article • The Journal of Alternative and Complementary Medicine, October 2008, Mary Ann Liebert Inc

    Professor shang hongcai

  61. Administration and quality control of large-scale clinical trials of traditional Chinese medicine

    Article • Journal of Chinese Integrative Medicine, January 2007, Journal of Chinese Integrative Medicine Press

    Professor shang hongcai